Delivery Order SPE2DB22D1103-SPE2DB24FTNF7

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTARIX vaccine oral syringe 1.5ML. The contract has a ceiling value of $13,629.96 and a completion date of October 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTARIX vaccine oral syringe 1.5ML. The contract has a ceiling value of $7,237.20 and a completion date of June 12, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX vaccine oral syringes 1.5ML, with a ceiling value of $3,290.49 and a completion date of March 19, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rotarix vaccine oral syringes. The $4,301.45 firm fixed-price contract has a completion date of February 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the ROTARIX vaccine in oral syringes. The contract has a ceiling value of $1,514.90 and a period of performance through December 30, 2024. It is a firm-fixed price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ROTARIX Vaccine Oral Syringes. The contract has a ceiling value of $22,410.83 and is a firm fixed-price delivery order, with a period of performance ending on May 21, 2025. The contract is not set aside for any specific business size or socioeconomic category. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of the ROTARIX vaccine in oral syringes. The contract has a ceiling value of $2,214.99 and a period of performance through February 2025. It is a firm-fixed-price contract, indicating a pre-determined price for the deliverables. The contract is not designated as a set-aside, suggesting it was competitively awarded....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ROTARIX vaccine oral syringes 1.5 mL, with a ceiling value of $7,383.30 and a period of performance through May 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the ROTARIX VACCINE ORAL SYRINGE 1.5ML product, with a firm fixed price of $5,906.64 and an ultimate completion date of June 6, 2025. This delivery order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,464.80, is for the supply of the ROTARIX vaccine oral syringe 1.5 mL. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTNF7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ROTARIX vaccine oral syringes. The contract has a total ceiling value of $5,418.15 and a performance period ending on July 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which enables efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:12 AM